The present invention provides a method of improving survival associated with cancer in a subset of the general population. The invention provides a method of improving survival associated with cancer in patients of Asian ethnic background. In addition, the present application relates to the treatment of angiogenesis related disease in an Asian patient with kinase inhibitors. In addition the present application relates to the treatment of non-small cell lung cancer in an Asian patient with motesanib.本發明提供一種改善一般人口子集中與癌症相關聯之存活率之方法。本發明提供一種改善亞洲族群背景之患者中與癌症相關聯之存活率之方法。另外,本申請案係關於利用激酶抑制劑治療亞洲患者之血管生成相關疾病。另外,本申請案係關於利用莫替沙尼(motesanib)治療亞洲患者之非小細胞肺癌。
